New Lundbeck exec to get firm's next research leg started
Lundbeck's executive group used a strict checklist to find its new head of R&D, and Tarek Samad, who will be taking on the job on May 1, scored top marks on one parameter in particular.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Lundbeck's decision to find a new head of research and development is part of a major reorganization of the company's R&D unit, which has been going on for a while, the Danish pharmaceutical firm's Executive Vice President & Head of Research & Development Johan Luthman tells MedWatch.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck poaches CSO from US biotech firm
For subscribers
.jpg&w=384&q=75)
